SCY_4679 Antibody

What is SCY_4679 Antibody and what is its target protein?

SCY_4679 Antibody (CSB-PA409748XA01STA) is a research-grade antibody that targets a specific protein encoded by the SCY_4679 gene in Saccharomyces cerevisiae strain YJM789 (Baker's yeast). This antibody corresponds to UniProt accession number A6ZRW8 . The target protein functions within yeast cellular pathways, and the antibody serves as a valuable tool for detecting and studying this protein in various experimental contexts.

What formats and specifications are available for SCY_4679 Antibody?

SCY_4679 Antibody is commercially available in both concentrated (0.1ml) and diluted (2ml) formats . The antibody is typically supplied in a buffer solution optimized for stability and functionality. When designing experiments, researchers should consider the concentration and volume required for their specific applications, with the concentrated format often preferred for applications requiring higher antibody concentrations such as immunoprecipitation.

How does SCY_4679 Antibody compare to other yeast-specific antibodies?

Unlike other Saccharomyces cerevisiae antibodies that target proteins from the S288c strain (such as YOR020W-A, YNL228W, and XYL2 antibodies), SCY_4679 Antibody specifically recognizes proteins from the YJM789 strain . This strain specificity makes it particularly valuable for comparative studies between different yeast strains and for research specifically focused on the YJM789 strain, which has distinct genetic characteristics compared to other laboratory strains.

What are the optimal storage and handling conditions for SCY_4679 Antibody?

For maximum stability and performance, SCY_4679 Antibody should be stored at -20°C for long-term storage. When working with the antibody, it's recommended to aliquot the stock solution to avoid repeated freeze-thaw cycles, which can degrade antibody performance. Based on standard practices for research antibodies, each aliquot should ideally undergo no more than 5 freeze-thaw cycles.

For short-term storage (1-2 weeks), the antibody can be kept at 4°C. When handling the antibody, use sterile techniques and avoid contamination, which could introduce proteases that degrade antibody quality. The antibody should be centrifuged briefly before opening to collect all liquid at the bottom of the vial.

What are the recommended protocols for Western blotting with SCY_4679 Antibody?

For Western blotting applications with SCY_4679 Antibody, researchers should follow this optimized protocol:

• Sample Preparation: Prepare yeast protein extracts using standard cell lysis procedures, typically involving mechanical disruption with glass beads in a lysis buffer containing protease inhibitors.

• Gel Electrophoresis and Transfer: Separate proteins on an SDS-PAGE gel (10-12% typically works well for most yeast proteins) and transfer to a PVDF or nitrocellulose membrane.

• Blocking: Block the membrane with 5% non-fat dry milk or BSA in TBST (Tris-buffered saline with 0.1% Tween-20) for 1 hour at room temperature.

• Primary Antibody Incubation: Dilute SCY_4679 Antibody at a recommended starting ratio of 1:1000 in blocking solution and incubate overnight at 4°C with gentle rocking.

• Washing: Wash the membrane 3-4 times with TBST, 5 minutes each.

• Secondary Antibody Incubation: Incubate with an appropriate HRP-conjugated secondary antibody (typically anti-rabbit IgG if SCY_4679 is rabbit-derived) at 1:5000 dilution for 1 hour at room temperature.

• Signal Development: After washing, develop using ECL substrate and detect using a chemiluminescence imager system, similar to the approach described in other antibody studies .

For troubleshooting high background or weak signals, further optimization of antibody concentration, blocking conditions, and washing steps may be necessary.

How can I optimize immunofluorescence experiments with SCY_4679 Antibody?

To optimize immunofluorescence experiments with SCY_4679 Antibody in yeast cells:

• Fixation: Fix yeast cells with 4% paraformaldehyde in PBS for 15-20 minutes at room temperature, similar to protocols used for other cellular imaging studies .

• Permeabilization: Permeabilize with 0.1% Triton X-100 for 10 minutes to allow antibody access to intracellular targets .

• Blocking: Block with 2% BSA in PBS for 30 minutes to reduce non-specific binding .

• Primary Antibody: Dilute SCY_4679 Antibody at 1:200 initially (adjust as needed) in blocking solution and incubate for 1-2 hours at room temperature or overnight at 4°C.

• Secondary Antibody: After washing, incubate with appropriate fluorophore-conjugated secondary antibody at 1:200 dilution for 30-60 minutes .

• Nuclear Staining: Counterstain with Hoechst (0.6 μg/mL) for 30 minutes to visualize nuclei .

• Mounting: Mount slides using appropriate mounting medium to preserve fluorescence .

For co-localization studies, combine SCY_4679 Antibody with markers for specific cellular compartments, following protocols similar to those used in other subcellular trafficking studies .

What controls should be incorporated when working with SCY_4679 Antibody?

When designing experiments with SCY_4679 Antibody, include these critical controls:

• Negative Controls:

  • Secondary antibody only (omit primary antibody)

  • Isotype control antibody (non-specific antibody of same isotype)

  • SCY_4679 knockout strain (if available) or RNAi knockdown samples

• Positive Controls:

  • Overexpression system for the target protein

  • Known positive samples where target protein expression is well-characterized

• Specificity Controls:

  • Pre-absorption with purified antigen (should eliminate specific signal)

  • Validation in multiple techniques (Western blot, IF, IP) to confirm consistent target recognition

  • Cross-strain testing to assess strain specificity (S288c vs. YJM789)

These controls help distinguish specific signals from background and validate experimental findings, especially when working with antibodies targeting less-characterized proteins.

Can SCY_4679 Antibody be adapted for receptor-mediated transcytosis studies?

While SCY_4679 Antibody targets a yeast protein, the principles of antibody internalization and trafficking observed in mammalian cell models could inform adaptation strategies. Based on research with other antibodies, transcytosis studies require:

• Receptor Engagement Analysis: Determine if the SCY_4679 target can function as a cargo receptor by assessing its binding and internalization capabilities, similar to methodology used for other receptor studies .

• Internalization Assays: Modify the antibody for tracking intracellular movement through fluorescent labeling or biotinylation.

• Transcytosis Model Adaptation:

  • For in vitro studies, established protocols using transwell systems can be adapted, where antibodies are added to the apical chamber and measured in the basolateral chamber over time .

  • Measure antibody transport using ELISA detection methods similar to those used in other transcytosis studies .

• Sorting Pathway Analysis: Assess colocalization with endosomal markers (EEA1, Rab7) to determine the sorting pathway of the antibody, which is critical for understanding transcytosis potential versus lysosomal degradation .

This application would be particularly innovative as it bridges yeast research with mammalian transcytosis methodologies.

How effective is SCY_4679 Antibody for immunoprecipitation of protein complexes?

For immunoprecipitation (IP) applications with SCY_4679 Antibody:

• Lysate Preparation: Prepare yeast lysates under native conditions using gentle lysis buffers containing 150-300 mM NaCl, 1% non-ionic detergent (NP-40 or Triton X-100), 50 mM Tris-HCl (pH 7.5), and protease inhibitors.

• Pre-clearing: Pre-clear lysates with protein A/G beads to reduce non-specific binding.

• Antibody-Bead Preparation: Conjugate SCY_4679 Antibody to protein A/G beads (5-10 μg antibody per sample) using protocols similar to those established for other antibody studies.

• Immunoprecipitation:

  • Incubate pre-cleared lysate with antibody-conjugated beads overnight at 4°C with gentle rotation

  • Wash beads 3-5 times with washing buffer (lysis buffer with reduced detergent concentration)

  • Elute bound proteins with SDS sample buffer for Western blot analysis or with a gentle elution buffer for mass spectrometry

• Validation: Confirm successful IP through Western blotting of input, unbound, and eluted fractions.

For identifying novel interaction partners, eluted proteins can be analyzed by mass spectrometry following standard proteomic workflows.

What approaches can improve antibody-dependent cellular cytotoxicity (ADCC) studies with yeast-specific antibodies?

While SCY_4679 Antibody itself may not be directly applicable for ADCC studies due to its yeast target specificity, researchers interested in antibody effector functions can apply principles from other ADCC studies:

• Fc Engineering: If creating modified versions of SCY_4679 Antibody, researchers could incorporate Fc engineering principles to enhance binding to Fc receptors, similar to approaches used with other antibodies .

• Affinity Optimization: The binding affinity threshold necessary for effective antibody functions could be modeled after studies showing that increasing antibody binding affinity can significantly impact functional outcomes .

• Resistance Mechanism Analysis: When observing reduced antibody effectiveness over time, researchers should investigate potential epitope changes that may confer resistance, as observed in neutralization and ADCC studies .

• Controlled Fab-Arm Exchange: For creating bispecific antibodies incorporating SCY_4679 specificity, researchers can employ controlled fab-arm exchange (cFAE) methodology:

  • Introduce K409R mutation in one antibody and F405L in the other

  • Facilitate exchange using 2-MEA (2-Mercaptoethylamine)

  • Incubate at 31°C for 5 hours followed by desalting into PBS

This approach allows creation of antibodies with dual specificity, potentially useful for targeting the SCY_4679 antigen while recruiting effector cells or delivering cargo.

How can SCY_4679 Antibody be employed for comparative studies between different Saccharomyces strains?

For comparative strain studies with SCY_4679 Antibody:

• Cross-Reactivity Profiling:

  • Test antibody reactivity against proteins from multiple strains (YJM789, S288c, etc.)

  • Create a cross-reactivity matrix documenting signal intensity across strains

  • Determine epitope conservation through sequence alignment of the target region

• Strain-Specific Expression Analysis:

  • Quantify target protein expression levels across strains using calibrated Western blotting

  • Correlate expression differences with phenotypic variations between strains

  • Document strain-specific post-translational modifications that affect antibody recognition

• Evolutionary Conservation Study:

  • Extend testing to related yeast species to map evolutionary conservation

  • Identify regions of highest conservation (potential functional domains)

  • Create a phylogenetic map of target protein conservation

This approach provides valuable insights into strain-specific protein variations that may correlate with phenotypic differences.

What are common issues when using SCY_4679 Antibody and how can they be resolved?

When working with SCY_4679 Antibody, researchers may encounter these common issues:

• High Background in Western Blots:

  • Increase blocking time/concentration (try 5% BSA instead of milk)

  • Increase washing duration and number of washes

  • Optimize primary antibody dilution (try 1:2000-1:5000)

  • Use high-quality, freshly prepared buffers

• Weak or No Signal:

  • Verify protein expression in your samples

  • Reduce antibody dilution (try 1:500)

  • Increase exposure time during detection

  • Ensure proper antigen retrieval/sample preparation

  • Confirm antibody viability with a dot blot test

• Multiple Bands:

  • Verify if bands represent isoforms, post-translational modifications, or degradation products

  • Increase stringency of washing steps

  • Try reducing agent concentration adjustments

  • Run appropriate controls to identify specific bands

• Variable Results Between Experiments:

  • Standardize protocols rigidly

  • Prepare larger batches of buffers to reduce variability

  • Use internal loading controls

  • Consider lot-to-lot variations in antibody

For persistent issues, consulting the antibody manufacturer's technical support is recommended for product-specific troubleshooting guidance.

How can I validate SCY_4679 Antibody specificity for my particular experimental system?

To rigorously validate SCY_4679 Antibody specificity:

• Genetic Validation:

  • Test antibody in knockout/knockdown models

  • Compare with overexpression systems

  • Use CRISPR-modified strains with tagged endogenous protein

• Biochemical Validation:

  • Perform peptide competition assays

  • Conduct immunoprecipitation followed by mass spectrometry

  • Compare reactivity patterns across multiple antibodies to the same target

• Multi-technique Validation:

  • Confirm consistent target detection across Western blot, immunofluorescence, and immunoprecipitation

  • Document size consistency across techniques

  • Verify subcellular localization matches known distribution

• Cross-reactivity Assessment:

  • Test against related proteins

  • Screen across multiple yeast strains

  • Check against expected molecular weight

Comprehensive validation ensures experimental results are attributable to the specific target protein rather than non-specific interactions or artifacts.

What experimental design considerations are important when studying protein-protein interactions with SCY_4679 Antibody?

When designing protein-protein interaction studies:

• Binding Conditions Optimization:

  • Test multiple lysis buffer compositions (varying salt, detergent type/concentration)

  • Adjust pH conditions to maintain interaction integrity

  • Consider crosslinking approaches for transient interactions

• Control Selection:

  • Include IgG control immunoprecipitations

  • Perform reverse immunoprecipitations with antibodies to suspected interaction partners

  • Use relevant mutant strains lacking interaction domains

• Validation Strategies:

  • Confirm interactions by multiple methods (co-IP, proximity ligation assay, yeast two-hybrid)

  • Quantify interaction stoichiometry

  • Map interaction domains through truncation constructs

• Experimental Variables Consideration:

  • Test interactions under different physiological conditions

  • Examine effect of post-translational modifications

  • Assess impact of stress conditions on interactions

By addressing these considerations, researchers can generate more robust and reproducible protein-protein interaction data with SCY_4679 Antibody.

How can SCY_4679 Antibody be incorporated into multi-omics research approaches?

Integrating SCY_4679 Antibody into multi-omics research requires:

• Proteomics Integration:

  • Use antibody for immunoprecipitation followed by mass spectrometry

  • Combine with SILAC or TMT labeling for quantitative interaction proteomics

  • Correlate antibody-based detection with global proteome measurements

• Transcriptomics Correlation:

  • Compare protein levels detected by the antibody with corresponding mRNA levels

  • Investigate post-transcriptional regulation by analyzing protein-RNA ratios

  • Identify conditions where protein and transcript levels diverge

• Functional Genomics Connection:

  • Use the antibody to measure protein levels in genetic screening hits

  • Correlate genetic interaction networks with physical interaction networks

  • Assess protein localization changes in response to genetic perturbations

• Systems Biology Approach:

  • Map protein interactions identified by immunoprecipitation onto known pathway models

  • Develop predictive models incorporating antibody-detected protein levels

  • Identify network hubs through antibody-based interaction studies

This multi-faceted approach positions SCY_4679 Antibody as a central tool in comprehensive biological investigations rather than single-technique applications.

What considerations are important when adapting SCY_4679 Antibody for high-throughput screening applications?

For high-throughput adaptation:

• Assay Miniaturization:

  • Optimize antibody concentration for 384 or 1536-well formats

  • Develop robust signal detection with minimal volumes

  • Validate Z-factor scores >0.5 for assay quality

• Automation Compatibility:

  • Ensure antibody performance maintains consistency with automated liquid handlers

  • Develop stable working dilutions that retain activity during deck time

  • Optimize incubation times for automation workflow integration

• Signal Detection Optimization:

  • Select appropriate detection systems (fluorescence, luminescence, etc.)

  • Maximize signal-to-noise ratio

  • Establish clear positive/negative thresholds

• Data Analysis Pipeline:

  • Implement normalization strategies for plate and positional effects

  • Develop hit selection criteria with appropriate statistical thresholds

  • Create visualization tools for complex interaction patterns

With proper optimization, SCY_4679 Antibody can be effectively transitioned from traditional low-throughput applications to high-throughput screening platforms for identification of modulators of its target protein.